RAPT Therapeutics, Inc.
Developing immune-targeting therapies for inflammatory and immunologic diseases.
RAPT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US75382E1091
- LEI:
- Country:
- United States of America
- Address:
- 561 ECCLES AVENUE, 94080 SOUTH SAN FRANCISCO
- Website:
- https://rapt.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for inflammatory and immunologic diseases. The company's scientific approach focuses on developing therapeutics that intelligently target key drivers of the immune system to address significant unmet medical needs. Its pipeline includes candidates like Ozureprubart (RPT904), a long-acting anti-IgE antibody in development for food allergies, among other potential treatments for various conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all RAPT Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for RAPT Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for RAPT Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
